T1	Outcomes 1117 1151	Sustained virologic response (SVR)
T2	Outcomes 1347 1366	cohort, SVR24 rates
T3	Outcomes 1463 1482	cohort, SVR24 rates
T4	Outcomes 1558 1572	The SVR24 rate
T5	Outcomes 1645 1668	between SVR12 and SVR24
T6	Outcomes 1718 1738	were nasopharyngitis
T7	Outcomes 1745 1757	and headache
